Navigation Links
Hospira Japan Receives Approval for New Indication for 'Precedex IV™ 200ug'
Date:8/22/2010

provides sedation without causing significant respiratory depression. Precedex was first approved in 1999 in the United States, and is now used in more than 30 nations and regions. In 2004, Precedex was approved and launched in Japan and the sedative is now widely used by the nation's anesthesiologists and intensive care units.

Sedation with Precedex can be continued safely for an extended period, so that sedation can be continued uninterrupted before, during and after mechanical ventilation. Clinically significant episodes of bradycardia, sinus arrest and hypotension have been associated with Precedex infusion and may necessitate medication intervention.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 13,500 employees. Learn more at www.hospira.com.

About Hospira Japan

Hospira has been operating in Japan since March 2006. Hospira Japan Co., Ltd. offers specialty acute-care and oncology pharmaceuticals, and infusion therapy and medication management solutions. Through these highly specialized products, Hospira Japan offers solutions to the problems and challenges that healthcare professionals face in their clinical practice. As a partner that the patients and healthcare professionals can trust in, Hospira Japan holds high aspirations and contributes to the realization of the ease and safety in medical care. The Japan office is located in Osaka, and has approximately 80 employees
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
2. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
3. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
4. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
5. Hospira Names Daphne E. Jones Chief Information Officer
6. Hospira Reports Third-Quarter 2009 Results
7. Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants
8. Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010
9. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
10. Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
11. Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... -- "Whether it,s our family, our friends, all of ... a single sentence, Dr. Anthony Coyle , senior ... Centers for Therapeutic Innovation (CTI), sums up what ... biopharmaceutical companies. CTI,s unique model allows ... and the National Institutes of Health (NIH) to bridge ...
(Date:3/26/2015)... YORK , March 26, 2015 ... the average American consumer. However, a new survey ... various ailments from the common cold to diabetes, ... The research, conducted by the Private Label ... on over-the-counter healthcare products, including those essential for ...
(Date:3/26/2015)... Research and Markets ( ... "Global Smart Wearable Healthcare Devices and Services ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The analysts forecast ... market to grow at a CAGR of 30.42% ... covers the present scenario and the growth prospects ...
Breaking Medicine Technology:Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2Consumers can keep over-the-counter medicine affordable by using store brands 2Global Smart Wearable Healthcare Devices and Services Market 2015-2019 WITH Apple, At&T, Ee, Google, Samsung, Sprint, Telefonica & T-Mobile Dominating 2
... WOODCLIFF LAKE, N.J., Nov. 3, 2010 Par Pharmaceutical Companies, ... the third quarter ended September 30, 2010. For ... total revenues of $234.4 million and income from continuing operations ... included a $2.0 milestone payment to Tris Pharma, Inc., a ...
... 2010 Regado Biosciences, Inc., a privately held company ... agents, announced that Steven L. Zelenkofske, D.O., F.A.C.C., Senior ... at the American College of Chest Physicians (ACCP) Coagulation ... Vancouver, BC, Canada.  The abstract is titled "Sustained Inhibition ...
Cached Medicine Technology:Par Pharmaceutical Companies Reports Third Quarter 2010 Results 2Par Pharmaceutical Companies Reports Third Quarter 2010 Results 3Par Pharmaceutical Companies Reports Third Quarter 2010 Results 4Par Pharmaceutical Companies Reports Third Quarter 2010 Results 5Par Pharmaceutical Companies Reports Third Quarter 2010 Results 6Par Pharmaceutical Companies Reports Third Quarter 2010 Results 7Par Pharmaceutical Companies Reports Third Quarter 2010 Results 8Par Pharmaceutical Companies Reports Third Quarter 2010 Results 9Par Pharmaceutical Companies Reports Third Quarter 2010 Results 10Par Pharmaceutical Companies Reports Third Quarter 2010 Results 11Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010 2Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010 3
(Date:3/27/2015)... Georgia (PRWEB) March 27, 2015 To address ... shade issues, Super-Sod spent a year filming this video to ... needs and the shady environment it's often expected to thrive ... , All plants need light to survive. Anytime a sun-loving ... being put on a diet. Many homeowners try to amend ...
(Date:3/27/2015)... 2015 Canadian Cannabis Clinics ( ... and utilization of medical cannabis as a treatment ... doctors and clinics dedicated to providing access to ... gateway for patients searching for medical marijuana treatment ... launched their sub domain for Canada. , ...
(Date:3/27/2015)... 2015 The Florida Center for Brain ... Cure (ABC2), awarded $350,000 to support brain cancer research ... Scripps Research Institute and H. Lee Moffitt Cancer Center ... a clear development path and potential to provide meaningful ... future. , The awards fund research in areas ...
(Date:3/26/2015)... Calif. (PRWEB) March 26, 2015 Let’s ... grocery store. Fresh produce are today’s traffic magnets. Three ... particular supermarket because of their produce department, according to ... than ever as people are looking to add more ... Love Your Produce Manager® Day is April 2. As ...
(Date:3/26/2015)... San Francisco, CA (PRWEB) March 26, 2015 ... webinars. These will be on the topics of the DAOM ... , The DAOM Program Overview Webinar will be hosted by ... program and provide the next steps on how to prepare ... to 12:30 p.m. March 25, March 27, April 1 and ...
Breaking Medicine News(10 mins):Health News:For Spring Turf Planting Season, Super-Sod Created a New How-To Video Entitled "Two Views on Shade and Turf" 2Health News:Canadian Cannabis Clinics (CCC) to Join the Canada.MarijuanaDoctors.com Network 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 3Health News:ACTCM Announces Upcoming Webinars 2
... Cellmark Inc.,(Nasdaq: ORCH ), a leading worldwide provider ... for the fourth quarter and,full year of 2007., ... the fourth,quarter of 2007 compared to $14.9 million for ... 2007, revenues were $60.3 million compared to $56.9,million for ...
... The International,Society for CNS Clinical Trials ... in Washington, DC, February 25-27. This organization,involves ... of the pharmaceutical industry, and governmental,drug-regulatory bodies ... safety,of drugs used to treat psychiatric and ...
... Health Net,s Roger and Erika Greaves; CNN,s ... of Humanity Award, SHERMAN OAKS, Calif., March 5 ... prevent pediatric,burns and to heal severely burned children, celebrated its ... on Feb. 21. The event,was attended by more than 700 ...
... N.J., March 5 Besler,& Company, Inc., a ... agreed to pay the United States $2.875 million, ... federal Medicare program, the,Justice Department announced today., ... company counseled hospital clients to improperly,increase charges to ...
... ten elderly adults on Medicare reports drinking more alcohol ... Brandeis University. , Even though alcohol problems are ... older adults are consuming alcohol in amounts that exceed ... at Brandeis Universitys Heller School for Social Policy and ...
... Answer That Question, BREA, Calif., March 5 ... site in the United States, now,helps pet owners ... are with a quick and humorous online Canine ... gauges pet owner,responses to determine their dog,s brain ...
Cached Medicine News:Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 2Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 3Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 4Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 5Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 6Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 7Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 8Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 9Health News:FDA Warning of Suicidal Risk Associated with Antidepressants in Juveniles and Young Adults Reviewed at Recent ISCTM Meeting 2Health News:Children's Burn Foundation's Benefit Raises More Than $875,000 for Burn Survivors and Prevention 2Health News:Children's Burn Foundation's Benefit Raises More Than $875,000 for Burn Survivors and Prevention 3Health News:New Jersey Healthcare Consulting Firm to Pay U.S. $2.875 Million to Resolve Allegations of Medicare Fraud 2Health News:New study sheds light on excessive drinking among the elderly 2Health News:Is Your Dog a Canine-stein or a Bonehead? 2Health News:Is Your Dog a Canine-stein or a Bonehead? 3
... Cycler is Thermo Electron's most advanced personal ... easy to use sophisticated onboard software and ... Designed to offer performance, accuracy and simplicity ... number of customer driven features built up ...
... Design With Exceptional Performance The ... interface might be the first ... MyCycler is designed for performance. ... a premium, its small footprint ...
96 well thermocycler with unique High Temperature Range (HTR) Peltier technology for fastest available heating and cooling rates up to 4C/sec with High Pressure Lid for automated sealing of PCR plate...
... Faster speeds, highest precision, more user-friendliness ... concept: this is the definition of the ... years nucleic acid research has been developing ... required of PCR Systems. To keep ...
Medicine Products: